Santen Pharmaceutical Co., Ltd. (SNPHF)
OTCMKTS
· Delayed Price · Currency is USD
10.53
-0.62 (-5.53%)
At close: Dec 9, 2024
Santen Pharmaceutical Market Cap
Santen Pharmaceutical has a market cap or net worth of $3.34 billion as of April 24, 2025. Its market cap has decreased by -9.54% in one year.
Market Cap
3.34B
Enterprise Value
2.79B
Revenue
1.92B
Ranking
n/a
PE Ratio
19.12
Stock Price
$10.53
Market Cap Chart
Since January 14, 1992, Santen Pharmaceutical's market cap has increased from 1.19B to 3.34B, an increase of 181.17%. That is a compound annual growth rate of 3.15%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SS Innovations International | 1.71B |
Endo Inc. | 1.62B |
Nika Pharmaceuticals | 1.02B |
Veradigm | 721.11M |
Northwest Biotherapeutics | 608.87M |
Elite Pharmaceuticals | 427.31M |
Glass House Brands | 402.04M |
CytoDyn | 279.15M |